These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32127471)

  • 1. Abrogation of prenucleation, transient oligomerization of the Huntingtin exon 1 protein by human profilin I.
    Ceccon A; Tugarinov V; Ghirlando R; Clore GM
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5844-5852. PubMed ID: 32127471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing initial transient oligomerization events facilitating Huntingtin fibril nucleation at atomic resolution by relaxation-based NMR.
    Kotler SA; Tugarinov V; Schmidt T; Ceccon A; Libich DS; Ghirlando R; Schwieters CD; Clore GM
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3562-3571. PubMed ID: 30808748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Exchange NMR-Based Analysis of Huntingtin-SH3 Interactions Suggests an Allosteric Mechanism of Inhibition of Huntingtin Aggregation.
    Ceccon A; Tugarinov V; Clore GM
    J Am Chem Soc; 2021 Jun; 143(25):9672-9681. PubMed ID: 34137596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative NMR analysis of the kinetics of prenucleation oligomerization and aggregation of pathogenic huntingtin exon-1 protein.
    Ceccon A; Tugarinov V; Torricella F; Clore GM
    Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2207690119. PubMed ID: 35858329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profilin reduces aggregation and phase separation of huntingtin N-terminal fragments by preferentially binding to soluble monomers and oligomers.
    Posey AE; Ruff KM; Harmon TS; Crick SL; Li A; Diamond MI; Pappu RV
    J Biol Chem; 2018 Mar; 293(10):3734-3746. PubMed ID: 29358329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleation of Huntingtin Aggregation Proceeds via Conformational Conversion of Pre-Formed, Sparsely-Populated Tetramers.
    Torricella F; Tugarinov V; Clore GM
    Adv Sci (Weinh); 2024 Jun; 11(24):e2309217. PubMed ID: 38476051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploding the Repeat Length Paradigm while Exploring Amyloid Toxicity in Huntington's Disease.
    Wetzel R
    Acc Chem Res; 2020 Oct; 53(10):2347-2357. PubMed ID: 32975927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decorrelating Kinetic and Relaxation Parameters in Exchange Saturation Transfer NMR: A Case Study of N-Terminal Huntingtin Peptides Binding to Unilamellar Lipid Vesicles.
    Ceccon A; Clore GM; Tugarinov V
    J Phys Chem B; 2018 Dec; 122(49):11271-11278. PubMed ID: 30156416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Macromolecular Cosolutes on the Kinetics of Huntingtin Aggregation Monitored by NMR Spectroscopy.
    Torricella F; Tugarinov V; Clore GM
    J Phys Chem Lett; 2024 Jun; 15(24):6375-6382. PubMed ID: 38857530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the Interaction of Huntingtin Exon-1 Polypeptides with the Chaperonin Nanomachine GroEL.
    Wälti MA; Kotler SA; Clore GM
    Chembiochem; 2021 Jun; 22(11):1985-1991. PubMed ID: 33644966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleation Inhibition of Huntingtin Protein (htt) by Polyproline PPII Helices: A Potential Interaction with the N-Terminal α-Helical Region of Htt.
    Arndt JR; Chaibva M; Beasley M; Kiani Karanji A; Ghassabi Kondalaji S; Khakinejad M; Sarver O; Legleiter J; Valentine SJ
    Biochemistry; 2020 Feb; 59(4):436-449. PubMed ID: 31814404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-State Nuclear Magnetic Resonance on the Static and Dynamic Domains of Huntingtin Exon-1 Fibrils.
    Isas JM; Langen R; Siemer AB
    Biochemistry; 2015 Jun; 54(25):3942-9. PubMed ID: 26020223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.
    Chen M; Wolynes PG
    Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Targetable Self-association Surface of the Huntingtin exon1 Helical Tetramer Required for Assembly of Amyloid Pre-nucleation Oligomers.
    Mishra R; Gerlach GJ; Sahoo B; Camacho CJ; Wetzel R
    J Mol Biol; 2024 Jun; 436(12):168607. PubMed ID: 38734203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of Fast Tetramerization of the Huntingtin Exon 1 Protein Probed by Concentration-Dependent On-Resonance
    Ceccon A; Tugarinov V; Clore GM
    J Phys Chem Lett; 2020 Jul; 11(14):5643-5648. PubMed ID: 32589032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and Dynamics of the Huntingtin Exon-1 N-Terminus: A Solution NMR Perspective.
    Baias M; Smith PE; Shen K; Joachimiak LA; Żerko S; Koźmiński W; Frydman J; Frydman L
    J Am Chem Soc; 2017 Jan; 139(3):1168-1176. PubMed ID: 28085263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huntingtin's N-Terminus Rearrangements in the Presence of Membranes: A Joint Spectroscopic and Computational Perspective.
    Levy GR; Shen K; Gavrilov Y; Smith PES; Levy Y; Chan R; Frydman J; Frydman L
    ACS Chem Neurosci; 2019 Jan; 10(1):472-481. PubMed ID: 30149694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 17-residue-long N terminus in huntingtin controls stepwise aggregation in solution and on membranes via different mechanisms.
    Pandey NK; Isas JM; Rawat A; Lee RV; Langen J; Pandey P; Langen R
    J Biol Chem; 2018 Feb; 293(7):2597-2605. PubMed ID: 29282287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSP90 recognizes the N-terminus of huntingtin involved in regulation of huntingtin aggregation by USP19.
    He WT; Xue W; Gao YG; Hong JY; Yue HW; Jiang LL; Hu HY
    Sci Rep; 2017 Nov; 7(1):14797. PubMed ID: 29093475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.
    Ehrnhoefer DE; Duennwald M; Markovic P; Wacker JL; Engemann S; Roark M; Legleiter J; Marsh JL; Thompson LM; Lindquist S; Muchowski PJ; Wanker EE
    Hum Mol Genet; 2006 Sep; 15(18):2743-51. PubMed ID: 16893904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.